Yun Yen

Medicine & Life Sciences

1. Neoplasms 59%
2. ribonucleotide reductase M2 45%
3. Breast Neoplasms 34%
4. IT-101 28%
5. gemcitabine 27%
6. KB Cells 21%
7. Hydroxyurea 21%
8. Hepatocellular Carcinoma 20%
9. GTI2040 17%
10. Therapeutics 17%
11. DNA Damage 16%
12. Growth 16%
13. Biomarkers 16%
14. Cholangiocarcinoma 15%
15. Small Interfering RNA 15%
16. Colorectal Neoplasms 15%
17. Genes 14%
18. 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 14%
19. Camptothecin 14%
20. DNA Repair 14%
21. Survival 13%
22. Cell Line 13%
23. Drug Therapy 13%
24. Neoplasm Metastasis 13%
25. Receptor, Fibroblast Growth Factor, Type 3 13%
26. Pharmacokinetics 12%
27. Carcinogenesis 12%
28. In Vitro Techniques 11%
29. Liver Neoplasms 11%
30. Cell Proliferation 11%
31. Messenger RNA 11%
32. Clone Cells 11%
33. Proteins 10%
34. Bortezomib 10%
35. MPT0L145 10%
36. Nanoparticles 10%
37. DNA 9%
38. Gene Expression 9%
39. Maximum Tolerated Dose 9%
40. Heterografts 9%
41. MicroRNAs 9%
42. Non-Small Cell Lung Carcinoma 9%
43. Arginine 9%
44. PHY 906 9%
45. cyclodextrin polymer 8%
46. Stem Cells 8%
47. Autophagy 8%
48. Apoptosis 8%
49. Oxaliplatin 8%